Updates in Metastatic Breast Cancer

Course Experts: Niti Patel, PharmD

Course Description: This course reviews new agents and new indications for treatment of metastatic breast cancer, as well as how to navigate the new algorithm of treating metastatic breast cancer based on recently published literature.

Credits: CEUs will be granted to pharmacists in disease state management/drug therapy.

Metastatic, Breast Cancer, HER2, Hormone Receptor (HR), Triple Negative Breast Cancer (TNBC), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), De Novo, Lymph Nodes, Trastuzumab Deruxtecan (T-DXd), Sacituzumab Govitecan, CDK 4/6 Inhibitors, Ribociclib, Elacestrant, Selective Estrogen Receptor Degrader (SERD), ESR1 Mutation, Aromatase Inhibitor (AI), Progression-Free Survival (PFS), Overall Survival (OS), Endocrine Therapy